|Causation in epidemiology|
M Parascandola, DL Weed
Journal of Epidemiology & Community Health 55 (12), 905-912, 2001
|The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US|
M Zeller, D Hatsukami
Tobacco control 18 (4), 324-332, 2009
|Defining a global research and policy agenda for betel quid and areca nut|
H Mehrtash, K Duncan, M Parascandola, A David, ER Gritz, PC Gupta, ...
The Lancet Oncology 18 (12), e767-e775, 2017
|Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: systematic review and meta-analysis|
DN Sinha, RA Suliankatchi, PC Gupta, T Thamarangsi, N Agarwal, ...
Tobacco control 27 (1), 35-42, 2018
|Patient autonomy and the challenge of clinical uncertainty|
M Parascandola, JS Hawkins, M Danis
Kennedy Institute of Ethics Journal 12 (3), 245-264, 2002
|Tobacco and the lung cancer epidemic in China|
M Parascandola, L Xiao
Translational lung cancer research 8 (Suppl 1), S21, 2019
|Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures|
R Mehrotra, A Yadav, DN Sinha, M Parascandola, RM John, O Ayo-Yusuf, ...
The lancet oncology 20 (4), e208-e217, 2019
|The poorest of poor suffer the greatest burden from smokeless tobacco use: A study from 140 countries|
DN Sinha, PC Gupta, A Kumar, D Bhartiya, N Agarwal, S Sharma, ...
Nicotine and Tobacco Research 20 (12), 1529-1532, 2018
|Analysis of alkaloids in areca nut-containing products by liquid chromatography–tandem mass spectrometry|
V Jain, A Garg, M Parascandola, P Chaturvedi, SS Khariwala, I Stepanov
Journal of agricultural and food chemistry 65 (9), 1977-1983, 2017
|Skepticism, statistical methods, and the cigarette: A historical analysis of a methodological debate|
Perspectives in biology and medicine 47 (2), 244-261, 2004
|Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods|
VW Rees, JM Kreslake, KM Cummings, RJ O'Connor, DK Hatsukami, ...
Cancer epidemiology, biomarkers & prevention 18 (12), 3225-3240, 2009
|Cigarettes and the US Public Health Service in the 1950s.|
American Journal of Public Health 91 (2), 196, 2001
|A historical review of RJ Reynolds’ strategies for marketing tobacco to Hispanics in the United States|
L Iglesias-Rios, M Parascandola
American journal of public health 103 (5), e15-e27, 2013
|Two Surgeon General's reports on smoking and cancer: a historical investigation of the practice of causal inference|
M Parascandola, DL Weed, A Dasgupta
Emerging themes in epidemiology 3 (1), 1-11, 2006
|Perception and current use of e-cigarettes among youth in China|
L Xiao, M Parascandola, C Wang, Y Jiang
Nicotine and Tobacco Research 21 (10), 1401-1407, 2019
|Secondhand smoke exposure during pregnancy: a cross-sectional analysis of data from Demographic and Health Survey from 30 low-income and middle-income countries|
S Reece, C Morgan, M Parascandola, K Siddiqi
Tobacco Control 28 (4), 420-426, 2019
|Tobacco harm reduction and the evolution of nicotine dependence|
American journal of public health 101 (4), 632-641, 2011
|Lessons from the history of tobacco harm reduction: the National Cancer Institute's Smoking and Health Program and the “less hazardous cigarette”|
Nicotine & tobacco research 7 (5), 779-789, 2005
|Providing a science base for the evaluation of tobacco products|
ML Berman, G Connolly, KM Cummings, MV Djordjevic, DK Hatsukami, ...
Tobacco regulatory science 1 (1), 76, 2015
|Provincial-level cancer burden attributable to active and second-hand smoking in China|
C Xia, R Zheng, H Zeng, M Zhou, L Wang, S Zhang, X Zou, K Sun, Z Yang, ...
Tobacco control 28 (6), 669-675, 2019